Rituximab for non-infectious Uveitis and Scleritis

ConclusionsOverall, RTX appeared to be both effective and well-tolerated as second or third-line therapy for patients with non-infectious uveitis and scleritis.

Source: Journal of Ophthalmic Inflammation and Infection - August 16, 2021 Category: Opthalmology Source Type: research